NCT06067932 is a clinical trial of Foot X rays in X-linked Hypophosphatemia, sponsored by Orthopedic Hospital Vienna Speising.

Who is sponsoring NCT06067932?

NCT06067932 is sponsored by Orthopedic Hospital Vienna Speising.

What drugs are being tested in NCT06067932?

Interventions in NCT06067932: Foot X rays, Clinical examination + scores.

What condition does NCT06067932 study?

NCT06067932 studies X-linked Hypophosphatemia.

Is NCT06067932 still recruiting?

NCT06067932 is currently completed. Last updated 10 October 2023.

Last reviewed 2023-10-10 · How we verify

NCT06067932

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Foot Disorders in X-linked Hypophosphatemia

Completed Last updated 10 October 2023

What this trial tests

trial testing Foot X rays in X-linked Hypophosphatemia in 28 participants. Completed in 1 July 2021.

Timeline

1 July 2020

Primary endpoint
1 July 2021

1 July 2021

Quick facts

Lead sponsor	Orthopedic Hospital Vienna Speising
Status	Completed
Study type	OBSERVATIONAL
Enrollment	28
Start date	1 July 2020
Primary completion	1 July 2021
Estimated completion	1 July 2021
Sites	1 location across Austria

Drugs / interventions tested

Foot X rays
Clinical examination + scores

Conditions studied

X-linked Hypophosphatemia — all drugs for X-linked Hypophosphatemia →

Sponsor

Orthopedic Hospital Vienna Speising

Who can join

Adults 16 to 100, any sex, with X-linked Hypophosphatemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to characterize foot pathologies using X-rays and clinical examination and assess related outcome scores in adolescents and adults with X-linked Hypophophatemia

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for X-linked Hypophosphatemia

Currently open trials in the same condition.

NCT06525636 — A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia · Phase 1, PHASE2 · recruiting

Other Orthopedic Hospital Vienna Speising trials

Trials by the same sponsor.

NCT06262204 — Hallux Valgus Correction Using the Metal Screw or the Human Allogeneic Cortical Bone Screw (Shark Screw). · NA · not yet recruiting
NCT03953430 — Gait Analysis in Children With Clubfoot Treated With Tibialis Anterior Tendon Transfer · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06067932 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Orthopedic Hospital Vienna Speising
Last refreshed: 10 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06067932.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing